Message #2 From:
NewsBot Date: July 12, 2005 01:00:00 AM
DUSA News DUSA Pharmaceuticals, Inc. to Host Conference Call Re Second Quarter 2005 Levulan'R' Kerastick'R' and BLU-U'R' Sales Update
WILMINGTON, Mass.--(BUSINESS WIRE)--July 12, 2005--DUSA Pharmaceuticals, Inc. (NASDAQ NMS:DUSA) announces that an update regarding second quarter Levulan Kerastick and BLU-U end user sales will be issued after the close on Thursday July 14, 2005, to be followed by a conference call at 8:45 a.m. Friday, July 15, 2005,
Friday, July 15, 8:45 a.m. Eastern
If calling from the US or Canada use the following toll-free number:
800.936.4602
Password - DUSA
For International callers use
507.726.3418
Password - DUSA
You will also be able to listen to a replay of the conference call
using the following numbers:
North American callers 800.334.2128
International callers 580.431.2986
The call will be accessible on our web site after the call at www.dusapharma.com.
DUSA Pharmaceuticals, Inc. is a biopharmaceutical company engaged primarily in the development of Levulan(R) Photodynamic Therapy (PDT) and Photodetection (PD) for multiple medical conditions, with its primary focus in dermatology. PDT and PD utilize light-activated compounds to induce a therapeutic or detection effect. DUSA maintains offices in Wilmington, MA, Valhalla, NY and Toronto, Ontario.
